CN103127548B - 促进神经缺损修复的人工神经导管的制备方法 - Google Patents
促进神经缺损修复的人工神经导管的制备方法 Download PDFInfo
- Publication number
- CN103127548B CN103127548B CN201310044225.2A CN201310044225A CN103127548B CN 103127548 B CN103127548 B CN 103127548B CN 201310044225 A CN201310044225 A CN 201310044225A CN 103127548 B CN103127548 B CN 103127548B
- Authority
- CN
- China
- Prior art keywords
- nerve
- phbv
- peo
- artificial nerve
- artificial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000005036 nerve Anatomy 0.000 title claims abstract description 83
- 230000007547 defect Effects 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 15
- 230000008439 repair process Effects 0.000 title abstract description 15
- 230000001737 promoting effect Effects 0.000 title abstract description 5
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 14
- 238000001523 electrospinning Methods 0.000 claims abstract description 11
- 239000000835 fiber Substances 0.000 claims abstract description 9
- 239000012620 biological material Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920001634 Copolyester Polymers 0.000 claims abstract description 5
- -1 polyoxyethylene Polymers 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940005605 valeric acid Drugs 0.000 claims abstract description 3
- 229920000520 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Polymers 0.000 claims description 38
- 239000002121 nanofiber Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 10
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000010408 film Substances 0.000 claims 4
- 239000004568 cement Substances 0.000 claims 2
- 238000010041 electrostatic spinning Methods 0.000 claims 2
- 102000011830 Neural cell adhesion Human genes 0.000 claims 1
- 108050002172 Neural cell adhesion Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 239000008366 buffered solution Substances 0.000 claims 1
- 210000003733 optic disk Anatomy 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 abstract description 9
- 230000015556 catabolic process Effects 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 7
- 239000012528 membrane Substances 0.000 abstract description 5
- 210000002569 neuron Anatomy 0.000 abstract description 5
- 229920000331 Polyhydroxybutyrate Polymers 0.000 abstract description 4
- 230000004663 cell proliferation Effects 0.000 abstract description 4
- 238000009832 plasma treatment Methods 0.000 abstract description 4
- 239000005015 poly(hydroxybutyrate) Substances 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 230000021164 cell adhesion Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000002163 immunogen Effects 0.000 abstract description 2
- 239000002062 molecular scaffold Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 210000003497 sciatic nerve Anatomy 0.000 description 6
- 241000700159 Rattus Species 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 210000000578 peripheral nerve Anatomy 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000005890 Neuroma Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000023362 neuron cell-cell adhesion Effects 0.000 description 1
- 230000007511 neuronal proliferation Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 210000001698 popliteal fossa Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 239000012890 simulated body fluid Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310044225.2A CN103127548B (zh) | 2013-01-31 | 2013-01-31 | 促进神经缺损修复的人工神经导管的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310044225.2A CN103127548B (zh) | 2013-01-31 | 2013-01-31 | 促进神经缺损修复的人工神经导管的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103127548A CN103127548A (zh) | 2013-06-05 |
CN103127548B true CN103127548B (zh) | 2014-09-10 |
Family
ID=48488409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310044225.2A Active CN103127548B (zh) | 2013-01-31 | 2013-01-31 | 促进神经缺损修复的人工神经导管的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103127548B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105310794B (zh) * | 2015-02-14 | 2019-10-25 | 南通大学 | 一种内壁具有取向性结构的多孔人工神经导管的制备方法 |
CN105748171B (zh) * | 2016-02-21 | 2017-09-15 | 新乡医学院 | 生物型神经导管 |
CN106075578B (zh) * | 2016-07-22 | 2019-05-03 | 东华大学 | 一种plga三维神经导管及其制备方法 |
CN106868708A (zh) * | 2017-02-16 | 2017-06-20 | 江苏大学 | 一种β‑环糊精/聚环氧乙烯抗菌膜及制备方法和用途 |
WO2019178358A1 (en) * | 2018-03-15 | 2019-09-19 | Lintec Of America, Inc. | Fabricating a carbon nanofiber yarn nerve scaffold |
CN108939168A (zh) * | 2018-08-14 | 2018-12-07 | 上海市第六人民医院东院 | 一种褪黑素神经导管组合物、神经导管及其制备方法和应用 |
CN110665066B (zh) * | 2019-09-17 | 2021-07-02 | 南通大学 | 一种含有激活因子的神经再生纳米纤维的制备方法 |
CN114288478B (zh) * | 2021-12-24 | 2022-11-29 | 南通大学 | 一种组织工程神经复合体及其制备方法和应用 |
CN114732956A (zh) * | 2022-04-20 | 2022-07-12 | 西南大学 | 一种体内降解与神经再生高度匹配的神经支架的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030087196A (ko) * | 2002-05-07 | 2003-11-14 | 정필훈 | 생체흡수성 신경 도관 및 이의 제조 방법 |
CN102166372A (zh) * | 2011-02-14 | 2011-08-31 | 东南大学 | 促进骨缺损修复的复合纳米纤维支架的制备方法 |
CN102688076A (zh) * | 2011-03-25 | 2012-09-26 | 广州迈普再生医学科技有限公司 | 一种神经导管及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8728817B2 (en) * | 2007-05-04 | 2014-05-20 | University Of Virginia Patent Foundation | Compositions and methods for making and using laminin nanofibers |
-
2013
- 2013-01-31 CN CN201310044225.2A patent/CN103127548B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030087196A (ko) * | 2002-05-07 | 2003-11-14 | 정필훈 | 생체흡수성 신경 도관 및 이의 제조 방법 |
CN102166372A (zh) * | 2011-02-14 | 2011-08-31 | 东南大学 | 促进骨缺损修复的复合纳米纤维支架的制备方法 |
CN102688076A (zh) * | 2011-03-25 | 2012-09-26 | 广州迈普再生医学科技有限公司 | 一种神经导管及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103127548A (zh) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127548B (zh) | 促进神经缺损修复的人工神经导管的制备方法 | |
Xie et al. | Tissue-engineered buccal mucosa using silk fibroin matrices for urethral reconstruction in a canine model | |
Xie et al. | Evaluation of stretched electrospun silk fibroin matrices seeded with urothelial cells for urethra reconstruction | |
CN105688274B (zh) | 一种聚己内酯/明胶电纺复合支架的制备工艺 | |
EP3072536B1 (en) | Hydrophilic electrospinning biological composite stent material used for tissue regeneration and preparation method and application thereof | |
CN106913393B (zh) | 一种人工神经支架及其制备方法与应用 | |
US10434216B2 (en) | Ultra-thin film silk fibroin/collagen composite implant and manufacturing method therefor | |
CN102525689B (zh) | 取向纳米纤维仿生神经导管及其制作方法 | |
CN104353111B (zh) | 一种用于腹壁缺损的生物修复材料及其制备方法 | |
JP6196217B2 (ja) | 筋線維断片を利用した筋組織再生 | |
CN110193098B (zh) | 一种多层梯度生物膜及其制备方法 | |
Jensen et al. | Biomimetic and synthetic esophageal tissue engineering | |
KR20100046037A (ko) | 생체 내에서 유강장기 또는 유강장기의 일부분의 재생을 증진하기 위한 보철기구 | |
CN111962210B (zh) | 一种聚己内酯/甲基丙烯酰化弹性蛋白纳米纤维复合膜及其制备方法和应用 | |
CN105079874A (zh) | 一种基于纳米技术的小口径人工血管的制备方法 | |
CN105233336B (zh) | 丝胶蛋白神经导管及其制备方法与应用 | |
CN109381732A (zh) | 负载生长因子小分子抑制剂的静电纺丝敷料、其制备方法及应用 | |
CN102166372B (zh) | 促进骨缺损修复的复合纳米纤维支架的制备方法 | |
CN101653624A (zh) | 复合纳米纤维小直径血管组织工程支架材料的制备方法 | |
CN102973981B (zh) | 促进骨缺损修复的可降解三维纤维支架的制备方法 | |
CN110538006A (zh) | 纤维增强的三维打印软骨脱细胞基质支架的制作方法 | |
CN113941033A (zh) | 一种双载药纳米纤维水凝胶复合软骨修复系统及其制备方法 | |
CN115364283A (zh) | 一种仿生界面多层复合神经支架及其制备方法与应用 | |
CN101695585B (zh) | 一种降解可控的组织工程角膜纤维支架及制备方法 | |
Lapomarda et al. | Engineering Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200201 Address after: Room 214 and 215, No. 254, South trade road, Zhujing Town, Jinshan District, Yangpu District, Shanghai 201500 Patentee after: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. Address before: 210096 Jiangsu city Nanjing Province four pailou No. 2 Patentee before: SOUTHEAST University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231204 Address after: Room J, 12th Floor, Building 1, No. 399, Zhongren Road, Jiading District, Shanghai, 200000 Patentee after: Shanghai Junze Leen Biotechnology Co.,Ltd. Address before: Room 214 and 215, No. 254 Trade South Road, Zhujing Town, Jinshan District, Yangpu District, Shanghai, 201500 Patentee before: Shanghai Golden Medical Insurance Bioengineering Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20241028 Address after: Room 303-2, No. 399 Fengzhuang North Road, Zhenxin Street, Jiading District, Shanghai 200000 Patentee after: Shanghai Yinshang Investment Management Group Co.,Ltd. Country or region after: China Address before: Room J, 12th Floor, Building 1, No. 399, Zhongren Road, Jiading District, Shanghai, 200000 Patentee before: Shanghai Junze Leen Biotechnology Co.,Ltd. Country or region before: China |